GUERBET (GBT.PA) Fundamental Analysis & Valuation
EPA:GBT • FR0000032526
Current stock price
11.44 EUR
-0.16 (-1.38%)
Last:
This GBT.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. GBT.PA Profitability Analysis
1.1 Basic Checks
- GBT had negative earnings in the past year.
- GBT had a positive operating cash flow in the past year.
- In multiple years GBT reported negative net income over the last 5 years.
- In the past 5 years GBT always reported a positive cash flow from operatings.
1.2 Ratios
- GBT has a Return On Assets of -11.65%. This is in the lower half of the industry: GBT underperforms 68.97% of its industry peers.
- GBT has a worse Return On Equity (-40.57%) than 74.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.65% | ||
| ROE | -40.57% | ||
| ROIC | N/A |
ROA(3y)-2.59%
ROA(5y)-1.78%
ROE(3y)-10.06%
ROE(5y)-6.59%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- In the last couple of years the Operating Margin of GBT has declined.
- GBT has a Gross Margin of 75.59%. This is amongst the best in the industry. GBT outperforms 89.66% of its industry peers.
- GBT's Gross Margin has been stable in the last couple of years.
- The Profit Margin and Operating Margin are not available for GBT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.59% |
OM growth 3Y-43.49%
OM growth 5Y-29.74%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.42%
2. GBT.PA Health Analysis
2.1 Basic Checks
- GBT does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, GBT has about the same amount of shares outstanding.
- Compared to 5 years ago, GBT has about the same amount of shares outstanding.
- The debt/assets ratio for GBT is higher compared to a year ago.
2.2 Solvency
- Based on the Altman-Z score of 1.61, we must say that GBT is in the distress zone and has some risk of bankruptcy.
- GBT has a Altman-Z score of 1.61. This is in the lower half of the industry: GBT underperforms 67.24% of its industry peers.
- GBT has a debt to FCF ratio of 9.84. This is a negative value and a sign of low solvency as GBT would need 9.84 years to pay back of all of its debts.
- GBT has a Debt to FCF ratio (9.84) which is comparable to the rest of the industry.
- GBT has a Debt/Equity ratio of 1.47. This is a high value indicating a heavy dependency on external financing.
- With a Debt to Equity ratio value of 1.47, GBT is not doing good in the industry: 79.31% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.47 | ||
| Debt/FCF | 9.84 | ||
| Altman-Z | 1.61 |
ROIC/WACCN/A
WACC6.18%
2.3 Liquidity
- GBT has a Current Ratio of 2.49. This indicates that GBT is financially healthy and has no problem in meeting its short term obligations.
- With a decent Current ratio value of 2.49, GBT is doing good in the industry, outperforming 70.69% of the companies in the same industry.
- GBT has a Quick Ratio of 1.27. This is a normal value and indicates that GBT is financially healthy and should not expect problems in meeting its short term obligations.
- With a Quick ratio value of 1.27, GBT perfoms like the industry average, outperforming 53.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.49 | ||
| Quick Ratio | 1.27 |
3. GBT.PA Growth Analysis
3.1 Past
- The earnings per share for GBT have decreased strongly by -769.32% in the last year.
- GBT shows a decrease in Revenue. In the last year, the revenue decreased by -6.50%.
- Measured over the past years, GBT shows a small growth in Revenue. The Revenue has been growing by 2.00% on average per year.
EPS 1Y (TTM)-769.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2277.6%
Revenue 1Y (TTM)-6.5%
Revenue growth 3Y1.45%
Revenue growth 5Y2%
Sales Q2Q%-5.5%
3.2 Future
- Based on estimates for the next years, GBT will show a very strong growth in Earnings Per Share. The EPS will grow by 100.64% on average per year.
- GBT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.03% yearly.
EPS Next Y-417.31%
EPS Next 2Y275.2%
EPS Next 3Y100.64%
EPS Next 5YN/A
Revenue Next Year-5.17%
Revenue Next 2Y0.06%
Revenue Next 3Y1.03%
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. GBT.PA Valuation Analysis
4.1 Price/Earnings Ratio
- GBT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for GBT. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GBT indicates a rather cheap valuation: GBT is cheaper than 93.10% of the companies listed in the same industry.
- Based on the Price/Free Cash Flow ratio, GBT is valued cheaper than 100.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 3.25 | ||
| EV/EBITDA | 5.1 |
4.3 Compensation for Growth
- A more expensive valuation may be justified as GBT's earnings are expected to grow with 100.64% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y275.2%
EPS Next 3Y100.64%
5. GBT.PA Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 2.69%, GBT has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 1.30, GBT pays a bit more dividend than its industry peers.
- Compared to an average S&P500 Dividend Yield of 1.82, GBT pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.69% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y275.2%
EPS Next 3Y100.64%
GBT.PA Fundamentals: All Metrics, Ratios and Statistics
EPA:GBT (4/30/2026, 5:21:43 PM)
11.44
-0.16 (-1.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Industry Strength8.11
Industry Growth9.33
Earnings (Last)04-23 2026-04-23
Earnings (Next)07-23 2026-07-23
Inst Owners8.83%
Inst Owner ChangeN/A
Ins Owners5.01%
Ins Owner ChangeN/A
Market Cap144.60M
Revenue(TTM)786.44M
Net Income(TTM)-108.33M
Analysts44
Price Target12.19 (6.56%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.69% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.81%
PT rev (3m)-8.08%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-78.86%
EPS NY rev (3m)-492.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.15%
Revenue NY rev (3m)-8.99%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.18 | ||
| P/FCF | 3.25 | ||
| P/OCF | 1.78 | ||
| P/B | 0.54 | ||
| P/tB | 0.7 | ||
| EV/EBITDA | 5.1 |
EPS(TTM)-8.5
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)3.52
FCFY30.76%
OCF(TTM)6.42
OCFY56.08%
SpS62.22
BVpS21.12
TBVpS16.26
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -11.65% | ||
| ROE | -40.57% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 75.59% | ||
| FCFM | 5.66% |
ROA(3y)-2.59%
ROA(5y)-1.78%
ROE(3y)-10.06%
ROE(5y)-6.59%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)4.11%
ROCE(5y)4.72%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-43.49%
OM growth 5Y-29.74%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.86%
GM growth 5Y-0.42%
F-Score4
Asset Turnover0.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.47 | ||
| Debt/FCF | 9.84 | ||
| Debt/EBITDA | 5.29 | ||
| Cap/Depr | 22.55% | ||
| Cap/Sales | 4.66% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 109.34% | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.49 | ||
| Quick Ratio | 1.27 | ||
| Altman-Z | 1.61 |
F-Score4
WACC6.18%
ROIC/WACCN/A
Cap/Depr(3y)65.96%
Cap/Depr(5y)64.56%
Cap/Sales(3y)6.22%
Cap/Sales(5y)6.41%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-769.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2277.6%
EPS Next Y-417.31%
EPS Next 2Y275.2%
EPS Next 3Y100.64%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.5%
Revenue growth 3Y1.45%
Revenue growth 5Y2%
Sales Q2Q%-5.5%
Revenue Next Year-5.17%
Revenue Next 2Y0.06%
Revenue Next 3Y1.03%
Revenue Next 5YN/A
EBIT growth 1Y-277.86%
EBIT growth 3Y-42.67%
EBIT growth 5Y-28.34%
EBIT Next Year317.55%
EBIT Next 3Y81.45%
EBIT Next 5YN/A
FCF growth 1Y83.59%
FCF growth 3YN/A
FCF growth 5Y-6.04%
OCF growth 1Y-0.16%
OCF growth 3Y38.62%
OCF growth 5Y-7.61%
GUERBET / GBT.PA Fundamental Analysis FAQ
What is the fundamental rating for GBT stock?
ChartMill assigns a fundamental rating of 3 / 10 to GBT.PA.
What is the valuation status of GUERBET (GBT.PA) stock?
ChartMill assigns a valuation rating of 3 / 10 to GUERBET (GBT.PA). This can be considered as Overvalued.
Can you provide the profitability details for GUERBET?
GUERBET (GBT.PA) has a profitability rating of 2 / 10.
Can you provide the financial health for GBT stock?
The financial health rating of GUERBET (GBT.PA) is 3 / 10.
Can you provide the expected EPS growth for GBT stock?
The Earnings per Share (EPS) of GUERBET (GBT.PA) is expected to decline by -417.31% in the next year.